Article Text

PDF
Outpatient liver biopsy: a prospective evaluation of 500 cases
  1. P Beddy1,
  2. I L Lyburn2,
  3. T Geoghegan3,
  4. O Buckley4,
  5. A R Buckley5,
  6. W C Torreggiani6
  1. 1Department of Radiology, The Adelaide and Meath Hospital, Dublin, Ireland
  2. 2The Cheltenham Imaging Centre, Cheltenham, UK
  3. 3Department of Abdominal Imaging and Gastroenterology, Vancouver General Hospital, Vancouver, Canada
  4. 4Department of Radiology, The Adelaide and Meath Hospital, Dublin, Ireland
  5. 5Department of Abdominal Imaging and Gastroenterology, Vancouver General Hospital, Vancouver, Canada
  6. 6Department of Radiology, Adelaide and Meath Hospital, Dublin, Ireland
  1. Correspondence to:
    Dr William C Torreggiani
    Department of Radiology, Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland; william.torreggiani{at}amnch.ie

Statistics from Altmetric.com

Percutaneous core liver biopsy plays an important role in the management of parenchymal liver disease in establishing diagnosis, evaluating prognosis and monitoring the effect of therapy. Despite the first biopsy been carried out over 100 years ago, debate surrounds best practice.

Day case liver biopsy has become increasingly popular and has not been shown to be associated with increased complications.1,2 Under most day case regimens, patients are observed for up to six hours post biopsy but the majority of complications occur within the first hour post procedure and studies have suggested that the observation period may be reduced from the standard 4–6 h.3–5

Our study prospectively evaluated short stay (1 hour observation) liver biopsy over a 3 …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.